Spain drafts waiting lists protocol:
This article was originally published in Clinica
Executive Summary
The Spanish parliament is considering legislation that establishes the criteria for regulating waits for consultancy appointments, diagnostics tests and surgical interventions, as well as a prioritisation protocol. The draft royal decree presented in parliament last week does not, however, set out maximum waiting times, but shifts the responsibility for establishing these onto the individual devolved regions. Neither does it regulate waits for these services in emergency cases. The regional health authorities are to produce guidelines on how to prioritise the management of specific conditions, and will be required to submit six-monthly waiting numbers and times to a national monitoring centre.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.